Research Article| Volume 25, ISSUE 5, P610-617, March 01, 1989

Measuring cholinergic sensitivity: I. Arecoline effects in bipolar patients

      This paper is only available as a PDF. To read, Please Download here.


      In a previous study, bipolar patients were found to be more sensitive than controls to induction of rapid eye movement (REM) sleep by the direct muscarinic agonist arecoline. We have replicated this observation in a new group of patients and controls. However, much overlap between groups was seen. Muscarinic supersensitivity appears to be present in some bipolar affective patients, but the REM induction procedure may not be the optimal method for measuring it.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Abramson LB
        • Brown AJ
        • Sitaram N
        A cardioacceleratory response to low-dose arecoline infusion during sleep in patients with major depressive disorder. Relationship to REM sleep function.
        Psychiatry Res. 1985; 16: 189-198
        • Berger M
        • Lund R
        • Bronisch T
        • von Zersssen D
        REM latency in neurotic and endogenous depression and the cholinergic REM induction test.
        Psychiatry Res. 1983; 10: 113-123
        • Berger M
        • Hochli D
        • Krieg Ch
        • Zulley J
        • Riemann D
        • von Zerssen D
        The diagnostic and therapeutic utility of cholinomimetics in affective disorders.
        in: Abstracts of the World Congress of Biological Psychiatry, Philadelphia1985
        • Dilsaver SC
        Cholinergic mechanisms in depression.
        Brain Res Rev. 1986; 11: 285-316
        • Gershon ES
        • Hamovit J
        • Guroff JJ
        • Dibble E
        • Leckman JF
        • Sceery W
        • Targum SD
        • Nurnberger Jr, JI
        • Goldin LR
        • Bunney Jr, WE
        A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands.
        Arch Gen Psychiatry. 1982; 39: 1157-1167
        • Gillin JC
        • Duncan WC
        • Pettigrew KD
        • Frankel BL
        • Snyder F
        Successful separation of depressed, normal, and insomniac subjects by EEG sleep data.
        Arch Gen Psychiatry. 1979; 36: 85-90
        • Gillin JC
        • Kelsoe J
        • Risch C
        • Darko D
        • Kaiin H
        • Janowsky D
        Cholinergic supersensitivity in depression?.
        in: Abstracts of the World Congress of Biological Psychiatry, Philadelphia1985
        • Jones D
        • Kelwala S
        • Bell J
        • Dube S
        • Jackson J
        • Sitaram N
        Cholinergic REM sleep induction: Response correlation with endogenous major depressive subtype.
        Psychiatry Res. 1985; 14: 99-110
        • Janowsky DS
        • El-Yousef K
        • Davis JM
        • Sekerke HT
        A cholinergic-adrenergic hypothesis of mania and depression.
        Lancet. 1972; ii: 632-635
        • Knowles JB
        • Cairns J
        • MacLean AW
        • Delva N
        • Prowse A
        • Waldron J
        • Letemendia FJ
        The sleep of remitted bipolar depressives: Comparison with sex and age-matched controls.
        Can J Psychiatry. 1986; 31: 295-298
        • Kupfer DJ
        REM latency: A psychobiologic marker for primary depressive disease.
        Biol Psychiatry. 1976; 11: 159-174
        • Mazure C
        • Gershon ES
        Blindness and reliability in lifetime psychiatric diagnosis.
        Arch Gen Psychiatry. 1979; 36: 521-525
        • Nurnberger Jr, JI
        Pharmacogenetics of psychoactive drugs.
        J Psychiatric Res. 1987; 21: 499-505
        • Nurnberger Jr, JI
        • Sitaram N
        • Gershon ES
        • Gillin JC
        A twin study of cholinergic REM induction.
        Biol Psychiatry. 1983; 18: 1161-1173
        • Nurnberger Jr, JI
        • Berrettini WH
        • Mendelson W
        • Soncrant TI
        • Sack D
        • Gershon ES
        Cholinergic REM sleep induction: Effects of arecoline in man and in rat brain.
        Soc Neurosci Abstr. 1985; 11: 655
        • Nurnberger Jr, JI
        • Berrettini W
        • Goldin L
        • Gershon ES
        Genetic methods in neuropsychiatric disorders.
        in: Hingtgen JN Hellhammer D Huppmann G Advanced Methods in Psychobiology. C.J. Hogrefe, New York1987: 221-235
        • Sagales T
        • Brill S
        • Domino EF
        Differential effects of scopolamine and chlorpromazine on REM and NREM sleep in normal male subjects.
        Clin Pharmacol Ther. 1969; 10: 522-529
        • Sitaram N
        • Gillin JC
        Development and use of pharmacological probes of the CNS in man: Evidence of cholinergic abnormality in primary affective illness.
        Biol Psychiatry. 1980; 15: 925-955
        • Sitaram N
        • Nurnberger Jr, JI
        • Gershon ES
        • Gillin JC
        Faster cholinergic REM sleep induction in euthymic patients with primary affective illness.
        Science. 1980; 208: 200-202
        • Sitaram N
        • Moore AM
        • Vanskiver C
        • Blendy J
        • Nurnberger Jr, JI
        • Gershon ES
        • Gillin JC
        Hypersensitive cholinergic functioning in primary affective illness.
        in: Pepeu G insky H Cholinergic Mechanisms. Plenum Press, New York1981: 947-962
        • Sitaram N
        • Nurnberger Jr, JI
        • Gershon ES
        • Gillin J
        Cholinergic regulation of mood and REM sleep: Potential model and marker of vulnerability to affective disorder.
        Am J Psychiatry. 1982; 139: 571-576
        • Sitaram N
        • Jones D
        • Dube S
        • Bell J
        • Rivard P
        Supersensitive ACH REM-induction as a genetic vulnerability marker of MDD.
        in: Abstracts of the World Congress of Biological Psychiatry, Philadelphia1985
        • Sitaram N
        • Jones D
        • Dube S
        • Keshavan M
        • Bell J
        • Davies A
        • Reynal P
        The association of supersensitive cholinergic REM-induction and affective illness within pedigrees.
        J Psychiatr Res. 1987; 21: 487-497
      1. Neuronal activity during the sleep-waking cycle. Prog Neurobiol. 6. 1976: 279-376